1

Stayble Therapeutics

Stayble Therapeutics
Leadership team

Mr. Andreas Gerward M.Sc. (Co-Founder & CEO)

Mr. Mattias Munnich M.Sc. (Co-Founder & Chief Operating Officer)

Mr. Thomas Palsson M.Sc. (Chief Financial Officer)

Products/ Services
Biotechnology, Health Care, Medical Device, Therapeutics
Number of Employees
0 - 50
Headquarters
Göteborg, Vastra Gotaland, Sweden
Established
2012
Traded as
STO:STABL
Social Media
Overview
Location
Summary
Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.
History

Stayble Therapeutics was founded in 2011 with the mission of developing innovative medical solutions to improve people's quality of life. Over the years, our team of scientists and engineers have worked together to develop unique and groundbreaking products, such as the Stayble Bionic Arm and the Stayble TraumaPad.

Mission
Stayble Therapeutics is committed to improving the lives of our patients and customers, which is why we strive to create innovative products that deliver meaningful outcomes and experiences.
Vision
Our vision at Stayble Therapeutics is to make healthcare delivery more efficient, cost-effective, and personalized for all patients.
Key Team

Mr. Anders Lehmann Ph.D. (Chief Scientific Officer)

Recognition and Awards
Stayble Therapeutics has been recognized for excellence and innovation in medical technology, with numerous awards including the Global Health Award and the Medical Technology Innovator of the Year award.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Stayble Therapeutics
Leadership team

Mr. Andreas Gerward M.Sc. (Co-Founder & CEO)

Mr. Mattias Munnich M.Sc. (Co-Founder & Chief Operating Officer)

Mr. Thomas Palsson M.Sc. (Chief Financial Officer)

Products/ Services
Biotechnology, Health Care, Medical Device, Therapeutics
Number of Employees
0 - 50
Headquarters
Göteborg, Vastra Gotaland, Sweden
Established
2012
Traded as
STO:STABL
Social Media